INVO Bioscience Inc
NASDAQ:INVO
INVO Bioscience Inc
NASDAQ:INVO
Price:
0.78 USD
1.3%
Market Closed
Updated:
Jun 8, 2024
INVO Bioscience Inc
Total Liabilities & Equity
|
INVO Bioscience Inc
Total Liabilities & Equity Peer Comparison
Comparables:
BSX
SYK
ABT
ISRG
SWAV
Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
INVO Bioscience Inc
NASDAQ:INVO
|
Total Liabilities & Equity
$18.3m
|
CAGR 3-Years
22%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Total Liabilities & Equity
$36.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
9%
|
CAGR 10-Years
8%
|
|
|
Stryker Corp
NYSE:SYK
|
Total Liabilities & Equity
$39.4B
|
CAGR 3-Years
6%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Total Liabilities & Equity
$72.5B
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
6%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Total Liabilities & Equity
$15.8B
|
CAGR 3-Years
11%
|
CAGR 5-Years
14%
|
CAGR 10-Years
14%
|
|
|
Shockwave Medical Inc
NASDAQ:SWAV
|
Total Liabilities & Equity
$1.6B
|
CAGR 3-Years
83%
|
CAGR 5-Years
60%
|
CAGR 10-Years
N/A
|
See Also
What is INVO Bioscience Inc's Total Liabilities & Equity?
Total Liabilities & Equity
18.3m
USD
18.3m
USD
Based on the financial report for Mar 31, 2024, INVO Bioscience Inc's Total Liabilities & Equity amounts to 18.3m USD.
What is INVO Bioscience Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
39%
39%
Over the last year, the Total Liabilities & Equity growth was 198%. The average annual Total Liabilities & Equity growth rates for INVO Bioscience Inc have been 22% over the past three years , 39% over the past five years .
You don't have any saved screeners yet
